Superworth

Xenetic Biosciences free cash flow XBIO

Cash from operations less capital spending, by quarter and over the last twelve months, from 2013.

Last 12 months, to Dec 31, 2018
−$6.5M
Latest quarter, Q4 FY18
−$1M
−122% on a year earlier
Fiscal year 2018
−$6.5M
−535% on the year before

Xenetic Biosciences' free cash flow was −$6.5M over the twelve months to Dec 31, 2018, down 535% on a year earlier.

In its latest quarter, Q4 FY18, it was −$1M, down 122% on the same quarter a year before.

Free cash flow over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearFree cash flowChange
FY2018−$6.5M−535%
FY2017$1.5Mn/a
FY2016−$8.8Mn/a
FY2015−$5.3Mn/a
FY2014−$12.7Mn/a
FY2013n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedFree cash flowOn a year earlierLast 12 months
Q4 FY18−$1M−122%−$6.5M
Q3 FY18−$1.7Mn/a−$584.8K
Q2 FY18−$2.1Mn/a−$553.8K
Q1 FY18−$1.7M−705%−$457.3K
Q4 FY17$4.8Mn/a$1.5M
Q3 FY17−$1.6Mn/a−$8M
Q2 FY17−$2Mn/a−$7.4M
Q1 FY17$275.4Kn/a−$6.7M
Q4 FY16−$4.6Mn/a−$8.8M
Q3 FY16−$1Mn/a−$5.3M
Q2 FY16−$1.4Mn/a−$6.2M
Q1 FY16−$1.8Mn/a−$5.1M

Against its peers

Companies in Healthcare nearest Xenetic Biosciences' size, closest first, today.

CompanyFree cash flow yield
XBIOXenetic Biosciencesn/m
OXBROXBRIDGE RE HOLDINGSn/m
EDUCEducational Development2.0%
GTIMGood Times Restaurants19.3%
MDRRMedalist Diversifiedn/m
BCGBinah Capital30.9%
VIPVulcan Infrastructure & Powern/m
MXCMexco Energy7.3%
CKXCKX Landsn/m
MSGMMotorsport Gamesn/m
ATCHAtlasClearn/m
Peer median13.3%

What the free cash flow tells you

Cash from operations minus capital spending. The cash the company could hand back or reinvest.

Seasonal and lumpy quarter to quarter. The TTM view is the one to trust.

More on Xenetic Biosciences

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.